Latest Insider Transactions at Phreesia, Inc. (PHR)
This section provides a real-time view of insider transactions for Phreesia, Inc. (PHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phreesia, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phreesia, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2020
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,669
-5.12%
|
$329,422
$38.21 P/Share
|
|
Oct 23
2020
|
Thomas Altier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,669
+4.87%
|
$0
$0.84 P/Share
|
|
Oct 22
2020
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
86,237
-34.95%
|
$3,190,769
$37.65 P/Share
|
|
Oct 22
2020
|
Thomas Altier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
86,237
+25.9%
|
$0
$0.84 P/Share
|
|
Oct 21
2020
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,834
-17.56%
|
$379,190
$35.0 P/Share
|
|
Oct 21
2020
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
9,281
+13.07%
|
$18,562
$2.03 P/Share
|
|
Oct 12
2020
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,779
-4.05%
|
$216,928
$32.13 P/Share
|
|
Oct 12
2020
|
Thomas Altier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,779
+3.89%
|
-
|
|
Oct 01
2020
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,774
-2.11%
|
$443,220
$30.93 P/Share
|
|
Oct 01
2020
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
4,477
-1.69%
|
$138,787
$31.38 P/Share
|
|
Oct 01
2020
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,377
+1.03%
|
$5,508
$4.71 P/Share
|
|
Sep 29
2020
|
Edward L Cahill Director |
BUY
Other acquisition or disposition
|
Direct |
24,306
+20.36%
|
-
|
|
Sep 29
2020
|
Edward L Cahill Director |
SELL
Other acquisition or disposition
|
Indirect |
606,465
-100.0%
|
-
|
|
Sep 29
2020
|
Edward L Cahill Director |
BUY
Other acquisition or disposition
|
Indirect |
106,465
+50.0%
|
-
|
|
Jun 11
2020
|
Scott Perricelli Director |
BUY
Other acquisition or disposition
|
Indirect |
572,862
+50.0%
|
-
|
|
Jun 11
2020
|
Scott Perricelli Director |
BUY
Other acquisition or disposition
|
Direct |
44,770
+50.0%
|
-
|
|
Jun 11
2020
|
Scott Perricelli Director |
SELL
Other acquisition or disposition
|
Indirect |
4,328,717
-100.0%
|
-
|
|
Jun 11
2020
|
Llr Capital Iv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
551,319
-100.0%
|
-
|
|
Jun 11
2020
|
Llr Capital Iv, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
551,319
+50.0%
|
-
|
|
Jun 11
2020
|
Llr Capital Iv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,777,398
-100.0%
|
-
|